26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
On the heels of record deal volume in 2018 and 2019, 2020 was supposed to be another banner year for...
Read More >
Not since the Great Recession of 2008 has the homebuilding industry faced a challenge like COVID-19....
Read More >
Delaware recently passed a bill, House Bill 199 (HB 199), which, among other things, amends the crim...
Read More >
Dear Sir/Madam, We would like to alert you to the new rules for entering the Russian Federation thr...
Read More >
On February 27, 2020, the Ninth Circuit issued a long-anticipated decision in Rizo v. Yovino. Consis...
Read More >
Foreign investment has been ripe for legislative change in the United Kingdom. The latest developmen...
Read More >